acetylcysteine has been researched along with Addison Disease and Cerebral Sclerosis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fatemi, A; Jones, R; Kambhampati, S; Kannan, R; Kannan, S; Kaufman, ML; Marx, JS; Murray, CF; Nemeth, CL; Ramireddy, R; Rosen, M; Singh, S; Theisen, B; Tiffany, C; Turk, BR; Watkins, PA | 1 |
| Basso, L; Cloyd, J; Kartha, RV; Orchard, PJ; Schröder, H; Zhou, J | 1 |
| Andreu, AL; Bianchi, P; Ferrer, I; Fourcade, S; Galino, J; López-Erauskin, J; Muñoz-Pinedo, C; Pujol, A | 1 |
| Bjoraker, KJ; Charnas, L; Orchard, PJ; Shapiro, EG; Tolar, J; Ziegler, RS | 1 |
| Furuya, H; Harayama, Y; Imanaka, T; Kashiwayama, Y; Maeda, T; Morita, M; Sato, R; Shimozawa, N; Suzuki, Y; Takahashi, N | 1 |
| Khan, M; Pahan, K; Singh, AK; Singh, I | 2 |
2 trial(s) available for acetylcysteine and Addison Disease and Cerebral Sclerosis
| Article | Year |
|---|---|
Mechanisms of Antioxidant Induction with High-Dose N-Acetylcysteine in Childhood Cerebral Adrenoleukodystrophy.
Topics: Acetylcysteine; Adolescent; Adrenoleukodystrophy; Antioxidants; Blood Chemical Analysis; Cells, Cultured; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Ferritins; Fibroblasts; Heme Oxygenase-1; Humans; Male; RNA, Messenger; Treatment Outcome | 2015 |
N-acetyl-L-cysteine improves outcome of advanced cerebral adrenoleukodystrophy.
Topics: Acetylcysteine; Adrenoleukodystrophy; Antioxidants; Brain Diseases; Child; Combined Modality Therapy; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Pilot Projects; Severity of Illness Index; Treatment Outcome | 2007 |
5 other study(ies) available for acetylcysteine and Addison Disease and Cerebral Sclerosis
| Article | Year |
|---|---|
Dendrimer-N-acetyl-L-cysteine modulates monophagocytic response in adrenoleukodystrophy.
Topics: Acetylcysteine; Adrenoleukodystrophy; Adult; Aged; Antioxidants; ATP Binding Cassette Transporter, Subfamily D, Member 1; ATP-Binding Cassette Transporters; Brain; Child; Dendrimers; Female; Humans; Male; Microglia; Middle Aged; Phenotype; Young Adult | 2018 |
Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy.
Topics: Acetylcysteine; Adenosine Triphosphate; Adrenoleukodystrophy; Age Factors; Analysis of Variance; Animals; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Brain; Buthionine Sulfoximine; Cell Death; Chromatin; Cyclophilins; Disease Models, Animal; Enzyme Inhibitors; Fibroblasts; Flow Cytometry; Galactose; Gene Expression Regulation; Glucose; Glutathione; Humans; Membrane Potential, Mitochondrial; Mice; Mice, Knockout; Microscopy, Electron, Transmission; Neuroprotective Agents; Oligopeptides; Oxidative Stress; Peptidyl-Prolyl Isomerase F; Permeability; Reactive Oxygen Species; Thioctic Acid; Time Factors; Tubulin; Vitamin E | 2012 |
Adrenoleukodystrophy: subcellular localization and degradation of adrenoleukodystrophy protein (ALDP/ABCD1) with naturally occurring missense mutations.
Topics: Acetylcysteine; Adrenoleukodystrophy; Animals; ATP Binding Cassette Transporter, Subfamily D, Member 1; ATP-Binding Cassette Transporters; CHO Cells; Cricetinae; Cricetulus; Fibroblasts; Humans; Leupeptins; Mutation, Missense; Proteasome Inhibitors; Subcellular Fractions | 2007 |
Cytokine-induced accumulation of very long-chain fatty acids in rat C6 glial cells: implication for X-adrenoleukodystrophy.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Acetylcysteine; Adrenoleukodystrophy; Animals; Astrocytes; Brain Chemistry; Cell Survival; Culture Media, Serum-Free; Cytokines; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Acids; Free Radical Scavengers; Genetic Linkage; Glioma; Interferon-gamma; Interleukin-1; Lipopolysaccharides; Microglia; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Oxidation-Reduction; Rats; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; X Chromosome | 1998 |
Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases.
Topics: Acetylcysteine; Adrenoleukodystrophy; Amitrole; Animals; Antioxidants; Apoptosis; Brain; Cells, Cultured; Ceramides; Cytokines; Diamide; DNA Fragmentation; Glutathione; Glutathione Disulfide; Hydrogen Peroxide; Inflammation; Interleukin-1; Multiple Sclerosis; Oxidation-Reduction; Pyrrolidines; Rats; Reactive Oxygen Species; Sphingomyelins; Thiocarbamates; Tumor Necrosis Factor-alpha | 1998 |